NYSE: VEEV - Veeva Systems

Yield per half year: +16.41%
Sector: Healthcare

Download the report: word Word , pdf PDF

1. Summary

Advantages

  • Positive review The stock's return over the last year (27.69%) is higher than the sector average (-99.26%).
  • Positive review The company's current efficiency (ROE=14.72%) is higher than the sector average (ROE=12.27%)

Disadvantages

  • Negative review Price (218.46 $) is higher than fair price (31.2 $)
  • Negative review Dividends (0%) are below the sector average (1.8652%).
  • Negative review Current debt level 1.2708% has increased over 5 years from 0%.

2. Share price and performance

2.1. Share price

2.2. News

2.3. Market efficiency

Veeva Systems Healthcare Index
7 days 4.4% -94.8% -3.1%
90 days 15% -99.3% -2.3%
1 year 27.7% -99.3% 42%

Positive review VEEV vs Sector: Veeva Systems has outperformed the "Healthcare" sector by 126.96% over the past year.

Negative review VEEV vs Market: Veeva Systems has significantly underperformed the market by -14.34% over the past year.

Positive review Stable price: VEEV is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.

Long period: VEEV with weekly volatility of 0.5326% over the past year.

3. Summary of the report

3.1. General

P/E: 56.2
P/S: 12.72

3.2. Revenue

EPS 3.03
ROE 14.72%
ROA 11.31%
ROIC 15.68%
Ebitda margin 22.65%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Negative review company.analysis.fundamental.minus11_title: The current price (218.46 $) is higher than the fair price (31.2 $).

Negative review Price is higher than fair: The current price (218.46 $) is 85.7% higher than the fair price.

4.2. P/E

Negative review P/E vs Sector: The company's P/E (56.2) is higher than that of the sector as a whole (50.18).

Positive review P/E vs Market: The company's P/E (56.2) is lower than that of the market as a whole (92.53).

4.2.1 P/E Similar companies

4.3. P/BV

Negative review P/BV vs Sector: The company's P/BV (7.38) is higher than that of the sector as a whole (0.0365).

Positive review P/BV vs Market: The company's P/BV (7.38) is lower than that of the market as a whole (24.49).

4.3.1 P/BV Similar companies

4.4. P/S

Negative review P/S vs Sector: The company's P/S indicator (12.72) is higher than that of the sector as a whole (5.26).

Positive review P/S vs Market: The company's P/S indicator (12.72) is lower than that of the market as a whole (49.94).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

Negative review EV/Ebitda vs Sector: The company's EV/Ebitda (54.46) is higher than that of the sector as a whole (16.14).

Positive review EV/Ebitda vs Market: The company's EV/Ebitda (54.46) is lower than that of the market as a whole (76.61).


5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Ebitda

Positive review Yield Trend: Rising and has grown by 22.45% over the last 5 years.

Negative review Earnings Slowdown: The last year's return (0%) is below the 5-year average return (22.45%).

Negative review Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (137.1%).

5.4. ROE

Positive review ROE vs Sector: The company's ROE (14.72%) is higher than that of the sector as a whole (12.27%).

Positive review ROE vs Market: The company's ROE (14.72%) is higher than that of the market as a whole (-4.21%).

5.5. ROA

Positive review ROA vs Sector: The company's ROA (11.31%) is higher than that of the sector as a whole (7.3%).

Positive review ROA vs Market: The company's ROA (11.31%) is higher than that of the market as a whole (7%).

5.6. ROIC

Positive review ROIC vs Sector: The company's ROIC (15.68%) is higher than that of the sector as a whole (13.31%).

Positive review ROIC vs Market: The company's ROIC (15.68%) is higher than that of the market as a whole (8.49%).

6. Finance

6.1. Assets and debt

Positive review Debt level: (1.2708%) is quite low in relation to assets.

Negative review Increasing debt: over 5 years, the debt has increased from 0% to 1.2708%.

Positive review Debt Covering: The debt is covered by 12.51% from net profit.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Negative review Low yield: The dividend yield of the company 0% is below the average for the sector '1.8652%.

7.2. Stability and increase in payments

Negative review Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Negative review Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Negative review Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Negative review Insider Selling More insider purchases by 331.87% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
12.01.2024 Zuppas Eleni Nitsa
Chief Marketing Officer
Sale 204.75 614 250 3000
12.01.2024 Zuppas Eleni Nitsa
Chief Marketing Officer
Buy 135.49 406 470 3000
14.12.2023 Cabral Timothy S
Director
Sale 181.44 907 200 5000
01.12.2023 Wallach Matthew J
Director
Buy 179.25 51 983 290
18.09.2023 Wallach Matthew J
Director
Sale 209.07 1 045 350 5000